Given Imaging's M2A Is Reimbursed by Oxford Health Plans In NY, NJ, and CT

ATLANTA (July 2, 2002) -- Given Imaging, Inc. (NASDAQ: GIVN) announced today that Oxford Health Plans issued a coverage policy for reimbursement of capsule endoscopy for the small intestine. Oxford Health Plans now offers capsule endoscopy reimbursement to those among its 1.6 million beneficiaries who may suffer from diseases of the small intestine within the noted indications.

"Coverage by Oxford Health Plans will facilitate the adoption and use of the Given System by the medical community", said Dr. Blair Lewis of Mt Sinai Hospital, New York. "This underscores the fact that that the Given Diagnostic platform has become the standard of care for diagnosing disorders of the small intestine."

In June, Empire Medicare Services issued a coverage policy for reimbursement of capsule endoscopy for the small intestine to those among its 5.4 million beneficiaries who may suffer from diseases of the small intestine within the noted indications. Also in June, Medicare coverage statements were by Palmetto GBA for South Carolina, Ohio, and West Virginia, and by Triple-S for Puerto Rico and The U.S. Virgin Islands.

In May, capsule endoscopy received a Medicare coverage statement from the National Heritage Insurance Co. in California and a non-Medicare coverage policy from Anthem Blue Cross and Blue Shield which covers eight states including Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Colorado, Nevada and Maine.

"We are pleased that Oxford Health Plans has issued a reimbursement statement given their strong presence in the New York metropolitan area. Following this announcement, formal reimbursement coverage statements from Medicare and non-Medicare payers will address a patient base of 22 million people in the United States," said Dr. Gavriel D. Meron, president and CEO of Given Imaging Ltd.

This press release contains forward-looking statements, including projections about our business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, words such as "anticipates," "estimates," "expects," "intends," "plans," "believes," "intends" and words and terms of similar substance used in connection with any discussion of future operating or financial performance identify such forward-looking statements. Those forward-looking statements are not guarantees of future performance and actual results could differ materially from our current expectations as a result of numerous factors, including but not limited to the following: changes in regulatory environment, our success in implementing our sales, marketing and manufacturing plan, protection and validity of patents and other intellectual property rights, the impact of currency exchange rates, the effect of competition by other companies, the outcome of future litigation, the reimbursement policies for our product from healthcare payors, and other risks disclosed in our filings with the U.S. Securities Exchange Commission.

19.Sept.'03